Background
==========

The health of farmers has been investigated, especially in relation to occupational exposures, such as toxic substances largely used in agriculture. Several studies reported that this population has a greater risk of several cancers (non-Hodgkin\'s lymphoma, Hodgkin\'s disease, multiple myeloma, prostate, connective tissue, skin, stomach, and brain) \[[@B1]\], respiratory diseases such as chronic obstructive pulmonary disease \[[@B2],[@B3]\], musculoskeletal pain \[[@B4],[@B5]\], reproductive outcomes \[[@B6]\] and accidents \[[@B7]\]. Some others also reported higher risk for neurologic diseases such as Parkinson's disease \[[@B8],[@B9]\] or cognitive decline and dementia \[[@B10]-[@B12]\]. On the other hand, some findings also suggested that this population would less often suffer from other conditions, such as cardiovascular diseases \[[@B1],[@B5],[@B6]\], some types of cancer (lung, colon, oesophagus and bladder \[[@B1]\]\[[@B5]\]) or asthma (particularly for farm exposure in the childhood \[[@B13],[@B14]\]). In terms of mortality, the literature suggests quite consistent results, showing a lower mortality for all causes of death, and particularly lower mortality by cancer \[[@B1],[@B5]\]; only few studies suggested the reverse such as in Australia \[[@B15]\].

Most of the literature concerns individuals still professionally active and only few studies specifically focused on elderly former farmers. Yet, regarding the health specificities reported in the active population of farmers, some differences in terms of health and aging can be expected at long-term at older ages. In a study conducted on a sub-sample of the Paquid cohort on 1 507 elders, the relative risk of developing Alzheimer\'s disease for men occupationally exposed to pesticides was 2.4 (IC = 1.0-5.6), and even higher for Parkinson\'s disease with RR = 5.6 (CI = 1.5-21.6) \[[@B11]\]. This excess risk of Parkinson's disease was also reported in a case--control study conducted on the Bordeaux area on 84 cases and 252 controls (OR = 2.2, CI = 1.1-4.3) \[[@B16]\]. Consequently, a specific study conducted in elderly former farmers may be relevant to better appreciate the long-term effects (delayed and/or cumulative effects) on health and aging of various agricultural exposures in the broad sense, such as to UV radiation, long-time hard work conditions, pesticides, high dust levels, diesel exhaust and solvents, endotoxins, animal virus.

Beyond the health effects of farming exposures, it appears also relevant to explore more largely the characteristics of the living environment of former farmers living in rural area, such as lower educational levels \[[@B17]\], lower retirement pensions in agriculture leading to rudimentary life conditions, geographical isolation with lack of public transportation and limited access to stores and services. Moreover, rural residents are more likely to face barriers in obtaining health care, with a growing desertification of medical and paramedical professionals (nurses, physical therapists, occupational therapists) \[[@B18]\]. The ongoing rationalization of health care provision may lead to potential consequences for rural people with longer travel times and waiting, lower levels of technology and more uneven resource distribution than in other areas \[[@B19]\].

However, these difficulties may be counter-balanced, at least in part, by some advantages of living in rural area. Compared to their urban peers, rural elders may have healthier lifestyle such as lower tobacco consumption \[[@B20],[@B21]\], greater physical activity by pursuance of agricultural activities, gardening, walking, fishing, hunting (...) \[[@B22]-[@B24]\] and specific dietary habits possibly richer in fruits and vegetables, but the scarce literature on the topic in this specific population shows inconsistent results \[[@B25]-[@B27]\]. Moreover, they often benefit from well-developed social networks with better conviviality, more frequent social interactions and higher integration into social networks to provide informal social support and greater mutual aid \[[@B17],[@B18]\]. In addition, living in rural area is often associated with lower stress and greater calmness, greater security, more spacious accommodations, often with green way.

Thus, the retirees from agriculture living in rural area may be particularly exposed to specific diseases, risk factors and difficulties in daily life, but may also benefit from protective factors which may significantly modulate the aging process. An extensive and global health approach could thus be particularly relevant in this population. Consequently, we decided to conduct the epidemiological AMI (A[grica]{.smallcaps}-M[sa]{.smallcaps}-Institut fédératif de recherche en santé publique / Aging Multidisciplinary Investigation) cohort on health and aging in retired farmers living in rural area. Beyond the epidemiological approach, we paid from the very beginning of the research, a specific attention to the development of a multidisciplinary approach, involving epidemiologists, neurologists, neuropsychologists, psychologists, geriatricians, ophthalmologists, pharmaco-epidemiologists, demographists, sociologists, neuro-imagers, geneticists and biostatisticians. Through this global approach, the main objectives of AMI were (1) to describe social and environmental characteristics of the sample, (2) to study health and aging with a specific attention to neurodegenerative disorders like Alzheimer's disease and related diseases and (3) to identify the agricultural and rural specificities which may impact health and aging. The present manuscript describes the rationale and the protocol of the AMI study.

Methods/design
==============

The AMI cohort is an epidemiological prospective study on health and aging conducted in former farm-owners and farm-workers living in rural setting in South-Western France. Thanks to this collaborative approach, several work packages will be developed as presented Figure [1](#F1){ref-type="fig"}.
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Inclusion procedure
-------------------

In 2007, the participants were randomly recruited from the reimbursement database of the unique French Farmer Health Insurance System (Mutualité Sociale Agricole, MSA) according to the following criteria: 1) Being aged 65 years and older at baseline, 2) Being retired from agriculture, 3) Having worked in agriculture for at least 20 years, 4) Being affiliated to the MSA under own name, and 5) Living in rural area (as defined by the French Institute of Statistics and Economic Studies, INSEE) in Gironde department, South-Western France. In order to get enough subjects from different socio-demographic profiles, we a priori determined the proportion of farm owners (one third of the sample) and of farm workers (two thirds). The Ethics Committee of the CHU (University Hospital) of Bordeaux approved this research according to the principles embodied in the Declaration of Helsinki.

Visits and procedures at baseline
---------------------------------

First, 2 193 individuals who fulfilled the inclusion criteria received a mail that briefly presented the study. Among them, 1 935 were contacted by telephone and for the 1 002 subjects who agreed to participate, the first visit was planned in the following days. Simultaneously, their GP's were informed of this invitation and also received a brief presentation of the cohort.

The neuropsychologist interview
-------------------------------

The first interview was conducted at home by a specially trained neuropsychologist using a standardised questionnaire. Informed and written consent was obtained at the beginning of the visit for all participants. The following data were collected during a two-hour interview: age, gender, marital status, educational level, income, former professional activities and psychological transition to retirement (characteristics of the transition to retirement, retirement related affects \[[@B28]\], retirement related causalities \[[@B29]\], satisfaction and adaptation to occupational inactivity \[[@B30],[@B31]\]). Social and material living environment was also investigated, such as social network, characteristics of the dwelling and accessibility of shops and services. The neuropsychologist also assessed restriction in activities of daily living through several scales, including basic Activities of Daily Living (ADL) \[[@B32]\], Instrumental ADL (IADL) \[[@B33]\], mobility \[[@B34]\], and homebound, as well as informal and professional assistance in daily difficulties. Regarding health-related data, the interviewer questioned the participants about subjective health, consultation to the GP's and specialists (neurologist, geriatrician), and also collected all the medications currently used (the Anatomical Therapeutic Chemical ATC coding was used). Anxiety state was assessed using the State Trait Anxiety Inventory (STAI) \[[@B35]\], depressive symptomatology by the Center for Epidemiologic Studies-Depression scale (CES-D) \[[@B36]\] and the Mini-International Neuropsychiatric Interview (MINI) for major depressive episodes \[[@B37]\].

Finally, a complete battery of neuropsychological tests was administered by the neuropsychologist. Were explored: 1) subjective cognitive complaint according to the QPC scale (Questionnaire de Plainte Cognitive) \[[@B38]\]; 2) the Mini-Mental State Examination (MMSE), for global cognitive performance \[[@B39]\]; 3) the Free and Cued Selective Reminding Test RL/RI-16 items (FCSRT) \[[@B40]\] and 4) the story recall subtest of the Wechsler memory scale \[[@B41]\] for episodic memory; 5) the visual Delayed Matching-to-Sample task (DMS48) for visual recognition \[[@B42]\]; 6) the Goblet test (Mokri *et al.* submitted) for visuo-spatial working memory; 7) the Digit Symbol Substitution Task \[[@B43]\] for psychomotor speed; 8) the Wechsler Similarities test \[[@B43]\] for abstract thinking; and 9) the Isaacs Set Test \[[@B44]\] for verbal fluency. At the end of the visit, the neuropsychologist gave a clinical conclusion regarding possible dementia, Parkinson's disease and depression.

The health interview by a geriatrician or a nurse
-------------------------------------------------

Few weeks after the neuropsychological examination, a second home visit *(The health visit)* was performed in all participants, except for deceased, refusals and or other reasons. This visit was conducted by a nurse, except for individuals suspected of suffering from dementia, Parkinson's disease and depression on the basis of the neuropsychologist's examination. For these latter, the visit was conducted by a geriatrician, who could also conduct a clinical examination to confirm or infirm the diagnosis and specify the aetiology.

The health visit consisted in an evaluation of dietary habits using a short food frequency questionnaire, a detection of malnutrition by the Mini-Nutritional Assessment, \[[@B45]\] an assessment of alcohol and tobacco consumption and anthropometric measurements (weight, waist, calf, and upper arm circumferences, and self-reported height). Blood pressure was measured twice at different times of the visit using a validated digital electronic tensiometer (OMRON® 705IT). The Semmes-Weinstein monofilament was used to detect lower limb neuropathy or to identify \"at risk\" feet \[[@B46]\]. Muscular strength (using the JAMAR® dynamometer), timed 3-meter walking test, sitting down and waking up from a chair, one leg stance were also evaluated. Self-reported Parkinson's disease and five symptoms were also examined (rest tremor, postural tremor, gait disturbance, micrographia and hypertonia). Respiratory symptoms were explored by a spirometry in order to detect obstructive dysfunction using Piko-6® and questionnaires on dyspnoea in daily activities and chronic obstructive pulmonary disease (using a validated questionnaire adapted from ECRHS study \[[@B47]\]). Finally, self-reported ocular diseases and visual impairment (self-reported and assessed using a reading test commonly used by French ophthalmologists (Parinaud test) or its equivalent for the illiterate (Rossano and Weiss test)), hearing impairment (deafness or self-reported difficulty following conversations in noisy situation), and dental problems and dentures use were also assessed. The homogeneity of the data collection between nurses and geriatricians was ensured by a similar training and a standardised questionnaire with detailed recommendations.

The dementia diagnosis procedure
--------------------------------

Finally, a case consensus conference attended by the geriatrician in charged of the *health visit* (LDC, SC) and three other dementia specialists' clinicians (JFD, AFS, SA) was conducted to finally confirm or infirm the diagnosis. The aetiology was assigned according to the National Institute of Neurological and Communication Disorders and Stroke/Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria \[[@B48]\] for Alzheimer's disease, National Institute of Neurologic Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences (NINCDS-AIREN) criteria for vascular dementia \[[@B49]\] and Diagnostic and Statistical Manual of Mental Disorders Third Edition Revided (DSM-III-R) \[[@B50]\] for Parkinson's disease dementia.

The self-administered questionnaire
-----------------------------------

Each participant was asked to fill in a self-administered questionnaire, which was picked up at the time of the *health visit*. This questionnaire concerned data on agricultural career, such as domains of activity, type of jobs and activity duration, pesticides exposures (using a question: "Have you ever been exposed to pesticides in your occupational activity?") and also the level of complexity of professional activities (adapted from the work of Shooler *et al.*. \[[@B51]\]). We also collected data on characteristics and comfort of the housing and on familial and social support using the MOS Social Support Survey questionnaire \[[@B52]\]. Hobby practice at different period of life (at ages 18 years, 40 years and currently) was also collected using a questionnaires adapted in French from Wilson \[[@B53]\] and Schooler \[[@B54]\]. Finally, quality of life (using a specific scale for elders; scale in validation in the AMI cohort), proactive coping subscale \[[@B55]\] and routinization preferences were also assessed \[56\].

Blood sampling
--------------

At a third step, a fasting blood sampling conducted at home has been proposed to all the participants. Biological measurements (blood glucose level after overnight fasting, glycosylated haemoglobin, creatinine blood level, cholesterol levels -total, HDL, LDL, LDL/HDL quotient, triglycerides, vitamins A and E) have been performed and a biological bank was constituted including DNA samples and plasma, serum and red blood cells samples kept frozen at −80°C.

Three-year reimbursements of medical care by the Farmer Health Insurance System
-------------------------------------------------------------------------------

Health reimbursements data were extracted from The Farmer Health Insurance database for the three years following the starting of the inclusions, i.e. from October 2007 to September 2010. In addition to the medications collected at the time of the neuropsychological visit, we thus obtained the three-year medication use (only those reimbursed by the Health Insurance, using the ATC codes). We also extracted data on medical (GP's and specialists) and paramedical consultations (dentists, nurses, physical therapists, speech therapists, chiropodists...), biological examinations (blood examinations, imaging...), and reimbursed materials (optical correction, hearing and dental prosthesis, wheelchair, respiratory assistance devices...). Finally, we also obtained data on the Long-Term Diseases ("Affection Longue Durée", ALD), which are the 30 chronic and costly diseases recognized by the French Insurance System and 100% covered.

Neuro-imaging
-------------

Brain MRI were performed on a sub-sample of the AMI cohort at the University Hospital of Bordeaux in the frame of the AMImage project in 2009--2011. A second wave of MRI will be conducted 3 years later in the frame of the AMImage2 project (Cf. Figure [2](#F2){ref-type="fig"}).

![Flow chart of the longitudinal procedure of follow-up of the AMI cohort.](1471-2458-12-558-2){#F2}

Longitudinal follow-up
----------------------

The participants included in 2007 will be seen at home three times between 2007 and 2013. After one year, a short phone interview is conducted by a neuropsychologist (Cf. Figure [2](#F2){ref-type="fig"}). All the other follow-up visits are conducted by a neuropsychologist but at home, following the same procedures than that of the baseline with: complete standardised neuropsychological testing, important modifications of living environment (house moving, bereavement...), health problems and hospitalization since the previous visit, medications, sensory and respiratory impairments, depressive symptomatology, disability, falls in the three last months, walking speed, diet and malnutrition risk, weight and height, tobacco and alcohol consumption. Similarly to baseline, an active research of dementia and Parkinson's disease was conducted; all cases being confirmed or not by both a geriatrician (after a clinical examination at home) and the case consensus conference. We also used a self-administered questionnaire to collect longitudinal data on hobbies, quality of life, anxiety trait \[[@B35]\]and routinization preferences.

Sample description and follow-ups
---------------------------------

At baseline, the participation rate was 52%. As presented Figure [2](#F2){ref-type="fig"}, of the 1002 subjects of the initial sample, 904 had the health interview (N = 98, 73 refused, 16 were deceased and 9 were not visited for other reasons), of whom 204 received the visit of the physician for diagnosis confirmation. The self-administered questionnaire was filled-in by 637 of the participants, 696 subjects agreed having the blood sampling and 316 had brain MRI (Cf. Figure [2](#F2){ref-type="fig"}).

When comparing refusals and participants on the data available in the sampling dataset, no statistical differences were observed by age (mean 75.1 years (standard deviation, SD 6.6) vs. 75.0 years (6.6), p = 0.64), neither by gender (40.0% of women in the refusals vs. 37.5% in the participants, p = 0.27). We noticed a slight higher rate of refusal in the farm workers compared to the farm managers (50.2% and 45.4% respectively, p = 0.0531).

Compared to the general population of the area (census data of the Gironde area), the age distribution (21.6% of 65--69 years, 24.8 % of 70--74, 24.4% of 75--79 and 29.3% of 80 years and over) was not significantly different (respectively according to the census: 23.4%, 23.7%, 21.6% and 31.3%, p = 0.084). However, the AMI sample was significantly younger than the agricultural elderly population of former farmers of the area, since only 53.7% of our cohort were aged 75 years and over vs. 64.7% of the agricultural population (p \< 0.0001). Moreover, the cohort was not representative in terms of sex, since participants had to be affiliated to the Health Insurance under own name to be selected from the initial dataset. The initial sample thus included 62.5% of men (compared to 40.4% in the general population and 45.8% in the agricultural population of the area).

As presented Figure [2](#F2){ref-type="fig"}, 733 subjects were visited at the first follow-up visit at home conducted 2 years later, 114 were deceased, 86 only accepted a phone interview, 68 refused the visit and 1 was lost of follow-up. The next visit will start in June 2012.

Discussion
==========

This is the first French longitudinal study on health and aging in a population exclusively constituted by elderly farmers living in rural area and conducted through an extensive multidisciplinary approach. Two characteristics of this population will be focused on: living in rural area with the associated difficulties but also its beneficial effects, and being retired from agriculture with the potential long-term effects of farming exposures and agriculture-related factors.

To develop a global and multidisciplinary approach, the initial protocol of research was constructed in collaboration with several research teams, involving a large panel of disciplines, ranging from epidemiology to social and human sciences, from neuro-imaging to genetics. Moreover, the Farmer Health Insurance datasets of reimbursements of drugs, consultations and services and the administrative record of Long-Term Diseases significantly enrich the database of the cohort, with a major interest in combination with the data actively collected over the follow-ups of the study. For instance, a combination of these data with the active research of dementia and its clinical diagnosis may be relevant to study the proportion of undiagnosed cases of dementia, the frequency of treated patients or to describe their medical and paramedical care pathway. Moreover, all the visits (neuropsychologist, nurse and geriatrician, blood sampling) were conducted at home to limit the selection bias, especially in a population of elderly people, potentially frail, disabled, living sometimes in very distant and isolated villages and without public transportation. For all the visits conducted out-of-home (such as for MRI), taxis were systematically used.

Conclusion
==========

The aging population and the expected related growing burden of chronic diseases and age-related disorders will increase demand for health and social services, especially for specialties focusing on elderly patients. In addition to the potential long-term effects of agricultural exposures, the elderly farmers living in rural area probably faces multiple difficulties in daily life, sometimes largely greater than their urban peers. Nevertheless, those difficulties might also be counterbalanced by advantages of living in the rural environment. The aging process being highly multifactorial, the global approach developed in this cohort, based on a large variety of scientific complementary disciplines is stimulating and promising.
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